Article Text

PDF
The Amsler chart: absence of evidence is not evidence of absence
  1. Michael Crossland,
  2. Gary Rubin
  1. UCL Institute of Ophthalmology, London, UK; Moorfields Eye Hospital NHS Foundation Trust, London, UK
  1. Correspondence to: Dr M Crossland UCL Institute of Ophthalmology, 11–43 Bath Street, London EC1V 9EL, UK; m.crossland{at}ucl.ac.uk

Abstract

Early detection of the onset or progression of macular disease is likely to become increasingly important as new treatment modalities are introduced. Current best practice involves issuing patients with an Amsler chart for daily or weekly observation with the instruction to attend for immediate assessment should any new distortion be perceived. However the sensitivity of Amsler charts in detecting macular disease can be less than 50%, implying that presentation may be delayed in over half of patients with advancing disease relying on the Amsler chart to detect progression. A likely explanation for this is the phenomenon of perceptual completion whereby regular objects are “filled-in” across the scotoma. Although alternative tests have been developed and shown to have greater sensitivity, at present no straightforward, cheap, home-based test of macular disease progression is available. The development of such a self-diagnostic tool should be a research priority.

  • AMD, age-related macular disease
  • DMEM, Dulbecco’s modified essential medium
  • PHP, Preferential Hyperacuity Perimeter

Statistics from Altmetric.com

Footnotes

  • Competing interests: none

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • BJO at a glance
    Creig Hoyt